glp-1 agonists uses receptor GLP-1 Medications: Everything You Need

Your healthcare provider should take a thorough history before prescribing, specifically asking about personal or family history of thyroid cancer or MEN 2

Choosing between a medication that increases heart rate and blood pressure versus one that reduces MACE events by 20 percent is not a close call when cardiovascular health is a concern

Combining genetic insights and digital tools into care delivery is further improving therapeutic results

References

Future directions should prioritize RCTs targeting early-stage glaucoma, with primary endpoints encompassing both structural (e.g., OCT-based RGC metrics) and functional (e.g., visual field preservation) outcomes, to validate the potential of GLP-1RAs as a true disease-modifying strategy in glaucoma management

intriguingly, although oral semaglutide did not prove superiority over placebo for the primary outcome, it significantly lowered the incidence of death from cardiovascular causes (HR, 0.49